Risk of cardiovascular events. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy11

Brachial Artery Carotid Arteries Tunica Media Ankle Endothelium, Vascular Tunica Intima Cardiovascular System Coronary Vessels Femoral Artery Arteries Carotid Artery, Common

Organisms1

Chlamydophila pneumoniae

Diseases60

Cardiovascular Diseases Myocardial Infarction Stroke Coronary Artery Disease Hypertension Acute Coronary Syndrome Coronary Disease Diabetes Mellitus, Type 2 Atherosclerosis Diabetic Angiopathies Kidney Failure, Chronic Renal Insufficiency, Chronic Peripheral Vascular Diseases Plaque, Atherosclerotic Calcinosis Angina Pectoris Diabetes Complications Kidney Diseases Death, Sudden, Cardiac Heart Failure Carotid Artery Diseases Dyslipidemias Recurrence Disease Progression Death Albuminuria Peripheral Arterial Disease Thrombosis Metabolic Syndrome X Hypertrophy, Left Ventricular Hypercholesterolemia Angina, Unstable Myocardial Ischemia Diabetes Mellitus Vascular Calcification Inflammation Chronic Disease Coronary Stenosis Heart Diseases Hyperlipidemias Aortic Diseases Cerebrovascular Disorders Arteriosclerosis White Coat Hypertension Arteriosclerosis Obliterans Diabetic Nephropathies Intermittent Claudication Hemorrhage Atrial Fibrillation Angina, Stable Coronary Restenosis Vascular Diseases Asymptomatic Diseases Ventricular Dysfunction, Left Stroke, Lacunar Chlamydophila Infections Coronary Thrombosis Ischemic Attack, Transient Carotid Stenosis Renal Insufficiency

Chemicals and Drugs65

Biological Markers Hydroxymethylglutaryl-CoA Reductase Inhibitors C-Reactive Protein Platelet Aggregation Inhibitors Antihypertensive Agents Heptanoic Acids Pravastatin Aspirin Anticholesteremic Agents Cholesterol, LDL Pyrroles Ticlopidine Fluorobenzenes Hypolipidemic Agents Natriuretic Peptide, Brain Chlorthalidone Angiotensin-Converting Enzyme Inhibitors Cardiovascular Agents Cholesterol, HDL Fosinopril Cystatin C Amlodipine 1-Alkyl-2-acetylglycerophosphocholine Esterase Angiotensin II Type 1 Receptor Blockers Simvastatin Creatinine Phospholipases A2, Secretory Atenolol Lipids Tetrazoles Niacin Perindopril Hypoglycemic Agents Azetidines Cyclooxygenase 2 Inhibitors Ramipril Sulfonamides Blood Glucose Benzimidazoles Fibrinogen Particulate Matter Cholesterol Hemoglobin A, Glycosylated Margarine Indapamide Anti-Inflammatory Agents, Non-Steroidal Purinergic P2Y Receptor Antagonists Triglycerides Anticoagulants Diuretics Hydrochlorothiazide Adrenergic beta-Antagonists Calcium Channel Blockers Troponin T Hematinics Homocysteine Fatty Acids, Omega-3 Calcimimetic Agents Cystatins Vasodilator Agents Uric Acid Interleukin-6 Allylamine Fibrin Fibrinogen Degradation Products Placebos

Analytical, Diagnostic and Therapeutic Techniques and Equipment82

Risk Factors Follow-Up Studies Prospective Studies Proportional Hazards Models Predictive Value of Tests Risk Assessment Incidence Prognosis Treatment Outcome Cohort Studies Kaplan-Meier Estimate Blood Pressure Randomized Controlled Trials as Topic Double-Blind Method Risk Renal Dialysis Multivariate Analysis Coronary Angiography Drug Therapy, Combination Severity of Illness Index Angioplasty, Balloon, Coronary Chi-Square Distribution Retrospective Studies Blood Pressure Monitoring, Ambulatory Ankle Brachial Index Carotid Intima-Media Thickness Glomerular Filtration Rate Survival Rate Cause of Death Survival Analysis Endpoint Determination Odds Ratio Hospitalization Myocardial Revascularization Logistic Models Percutaneous Coronary Intervention Case-Control Studies Prevalence ROC Curve Disease-Free Survival Regression Analysis Platelet Function Tests Electrocardiography Longitudinal Studies Stents Blood Pressure Determination Cross-Sectional Studies Propensity Score Coronary Artery Bypass Registries Drug Chronotherapy Pulse Wave Analysis Kidney Function Tests Heart Rate Epidemiologic Methods Mortality Analysis of Variance Estrogen Replacement Therapy Tomography, X-Ray Computed Multicenter Studies as Topic Ultrasonography, Interventional Pulse Echocardiography Perioperative Period Blood Flow Velocity Drug-Eluting Stents Perioperative Care Clinical Trials as Topic Stroke Volume Diet Therapy Product Surveillance, Postmarketing Patient Selection Body Mass Index Sensitivity and Specificity Hemorheology Linear Models Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography Research Design Kidney Transplantation Echocardiography, Doppler Placebos Life Tables

Psychiatry and Psychology2

Smoking Risk Reduction Behavior

Phenomena and Processes26

Blood Pressure Time Factors Risk Chi-Square Distribution Carotid Intima-Media Thickness Glomerular Filtration Rate Odds Ratio Vascular Stiffness Circadian Rhythm Vasodilation Pulsatile Flow Heart Rate Systole Pulse Postmenopause Blood Flow Velocity Stroke Volume Body Mass Index Dose-Response Relationship, Drug Sensitivity and Specificity Hemorheology Ventricular Function, Left Platelet Aggregation Fibrinolysis Genotype Polymorphism, Genetic

Disciplines and Occupations2

Evidence-Based Medicine Research Design

Anthropology, Education, Sociology and Social Phenomena1

Sex Distribution

Technology, Industry, Agriculture2

Margarine Dietary Supplements

Information Science7

Incidence Survival Rate Cause of Death Prevalence Registries Mortality Life Tables

Named Groups1

Asian Continental Ancestry Group

Health Care53

Risk Factors Follow-Up Studies Prospective Studies Proportional Hazards Models Predictive Value of Tests Risk Assessment Incidence Treatment Outcome Cohort Studies Kaplan-Meier Estimate Randomized Controlled Trials as Topic Double-Blind Method Risk Multivariate Analysis Primary Prevention Secondary Prevention Severity of Illness Index Comorbidity Chi-Square Distribution Retrospective Studies Survival Rate Cause of Death Survival Analysis Odds Ratio Hospitalization Age Factors Logistic Models Case-Control Studies Prevalence ROC Curve Disease-Free Survival Regression Analysis Sex Factors Longitudinal Studies Cross-Sectional Studies Propensity Score Registries Epidemiologic Methods Mortality Analysis of Variance Multicenter Studies as Topic Epidemiologic Factors Perioperative Period Perioperative Care Practice Guidelines as Topic Clinical Trials as Topic Patient Selection Body Mass Index Sensitivity and Specificity Linear Models Cost-Benefit Analysis Sex Distribution Life Tables

Geographicals6

Japan United States Germany Italy South Dakota Denmark

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Technology, Industry, Agriculture Information Science Health Care Geographicals

Cardiovascular Diseases Risk Factors Follow-Up Studies Myocardial Infarction Prospective Studies Proportional Hazards Models Stroke Coronary Artery Disease Predictive Value of Tests Risk Assessment Biological Markers Hydroxymethylglutaryl-CoA Reductase Inhibitors Incidence Prognosis Hypertension Treatment Outcome C-Reactive Protein Acute Coronary Syndrome Cohort Studies Kaplan-Meier Estimate Platelet Aggregation Inhibitors Antihypertensive Agents Coronary Disease Diabetes Mellitus, Type 2 Heptanoic Acids Blood Pressure Time Factors Randomized Controlled Trials as Topic Atherosclerosis Pravastatin Double-Blind Method Risk Diabetic Angiopathies Kidney Failure, Chronic Aspirin Anticholesteremic Agents Renal Insufficiency, Chronic Cholesterol, LDL Renal Dialysis Pyrroles Japan Ticlopidine Peripheral Vascular Diseases Plaque, Atherosclerotic Calcinosis Fluorobenzenes Angina Pectoris Multivariate Analysis Brachial Artery Primary Prevention Coronary Angiography Diabetes Complications Secondary Prevention Hypolipidemic Agents Kidney Diseases Natriuretic Peptide, Brain Death, Sudden, Cardiac Heart Failure Drug Therapy, Combination Severity of Illness Index Carotid Artery Diseases Comorbidity Chlorthalidone Carotid Arteries Angioplasty, Balloon, Coronary Dyslipidemias Chi-Square Distribution Angiotensin-Converting Enzyme Inhibitors Retrospective Studies Blood Pressure Monitoring, Ambulatory Cardiovascular Agents Recurrence Disease Progression Cholesterol, HDL Ankle Brachial Index Fosinopril Tunica Media Carotid Intima-Media Thickness Glomerular Filtration Rate Death Survival Rate Albuminuria Cause of Death Peripheral Arterial Disease Thrombosis Metabolic Syndrome X Survival Analysis Endpoint Determination Hypertrophy, Left Ventricular Hypercholesterolemia Odds Ratio Hospitalization Ankle Age Factors Cystatin C Amlodipine Angina, Unstable Myocardial Ischemia Diabetes Mellitus Myocardial Revascularization

No FAQ available that match "risk of cardiovascular events"